Improvement of Neurodegenerative Disease after Use of Vemurafenib in Refractory BRAF V600E-Mutated Langerhans Cell Histiocytosis: A Case Report

Langerhans cell histiocytosis (LCH) is a rare histiocytic disorder characterized by heterogenous lesions infiltrated with CD1a+/CD207+ cells. Although LCH has a relatively good prognosis, the prognosis for patients with LCH refractory to standard chemotherapy is poor. Neurodegenerative LCH (ND-LCH)...

詳細記述

書誌詳細

出版年:	Clinical Pediatric Hematology-Oncology
主要な著者:	Young Kwon Koh, Su Hyun Yoon, Sung Han Kang, Hyery Kim, Ho Joon Im, Pyeong Hwa Kim, Ah Young Jung, Kyung-Nam Koh
フォーマット:	論文
言語:	英語
出版事項:	The Korean Society of Pediatric Hematology-Oncology 2022-10-01
主題:	lch langerhans cell histiocytosis vemurafenib
オンライン･アクセス:	https://doi.org/10.15264/cpho.2022.29.2.97